Clinical Trial Update: N-Acetylcysteine for Neuroprotection in Parkinson's Disease [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial investigating N-Acetylcysteine for neuroprotection in Parkinson's disease; study completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Parkinson Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-04-18